# Serina Therapeutics, Inc.: Form 8-K, filed Feb 14, 2024

- Company: [Serina Therapeutics, Inc.](/companies/ser.md) (CIK 1708599)
- Form: 8-K
- Filed: 2024-02-14
- Accepted by EDGAR: Feb 14, 2024, 16:15 ET
- Period: 2024-02-09
- Accession: 0001493152-24-006677
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1708599/000149315224006677/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1708599/000149315224006677/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1708599/000149315224006677/form8-k.htm

Filed Feb 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-006677. Last ingested by Listed: Nov 13, 2026, 15:52 ET. No prices; not investment advice.
